Clinical Trial

Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD)

Name: Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD) — clinical trial record (NCT07628972)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to see if a vitamin-like substance called quercetin is safe for people who have a rare condition called Dyskeratosis congenita (DC) or telomere biology disorders (TBD).

Trial Details

NCT Number	NCT07628972
Lead Sponsor	Children's Hospital Medical Center, Cincinnati
Conditions	Dyskeratosis Congenita, Telomere Disease
Enrollment	12 participants
Start Date	2026-05-29
Primary Completion	2028-09 (estimated)
Study Completion	2028-09 (estimated)
Updated on ClinicalTrials.gov	2026-06-05